Contribution of methamphetamine and insulin to the death of a woman suffering from type I diabetes - which played the greater role?
Language English Country United States Media print-electronic
Document type Journal Article, Case Reports
PubMed
38965163
PubMed Central
PMC11953177
DOI
10.1007/s12024-024-00855-y
PII: 10.1007/s12024-024-00855-y
Knihovny.cz E-resources
- Keywords
- Hypoglycemia, Insulin overdose, Legal consequences, Methamphetamine, Type I diabetes,
- MeSH
- Unconsciousness etiology chemically induced MeSH
- C-Peptide blood MeSH
- Diabetes Mellitus, Type 1 * complications blood drug therapy MeSH
- Fatal Outcome MeSH
- Hypoglycemic Agents * blood adverse effects MeSH
- Insulin * blood administration & dosage MeSH
- Blood Glucose analysis MeSH
- Humans MeSH
- Methamphetamine * blood adverse effects poisoning MeSH
- Amphetamine-Related Disorders * complications MeSH
- Central Nervous System Stimulants * blood adverse effects MeSH
- Dancing MeSH
- Physical Exertion MeSH
- Seizures chemically induced etiology MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- C-Peptide MeSH
- Hypoglycemic Agents * MeSH
- Insulin * MeSH
- Blood Glucose MeSH
- Methamphetamine * MeSH
- Central Nervous System Stimulants * MeSH
This report presents a fatal case of a young female Type I diabetic patient who developed convulsions and loss of consciousness after taking methamphetamine and spending some time in a dance club. During the convulsions, she was given sugar and when no response occurred, her boyfriend who was not experienced in the use of insulin administered a dose of insulin to her. The woman lost consciousness and died despite the efforts of the emergency service. A biochemical analysis revealed a high level of insulin (196.67 mU/L) and low levels of glucose (2.96 mmol/L) and C-peptide (26 pmol/L). Toxicological analysis revealed a methamphetamine concentration of 389 ng/mL and an amphetamine concentration of 19 ng/mL. The forensic perspective of the difficult determination of the contribution of each of the factors to the death, i.e., the pre-existing medical condition (Type I diabetes), the use of methamphetamine, the physical exertion at the dance club, and, finally, the non-indicated administration of insulin, is discussed. The ruling of the court is also reported.
See more in PubMed
Jelínek J, Pelc V, Říha J, Sovák Z, Bruna E, Heranová S et al. Trestní zákoník a trestní řád s poznámkami a judikaturou [Internet]. Leges; 2022 [cited 2024 Feb 13]. https://is.vsfs.cz/publication/10270/en/Trestni-zakonik-a-trestni-rad-s-poznamkami-a-judikaturou/Jelinek-Pelc-Riha-Sovak
Fryšták M. Odborné vyjádření versus znalecký posudek. Dny Práva–2010–Days Law. 2010;1.
Belsey S, Flanagan R. Postmortem biochemistry: current applications. J Forensic Leg Med. 2016;41:49–57. PubMed
Maeda H, Ishikawa T, Michiue T. Forensic biochemistry for functional investigation of death: concept and practical application. Leg Med. 2011;13:55–67. PubMed
Giugliano D, Ceriello A, Esposito K. Glucose metabolism and hyperglycemia. Am J Clin Nutr. 2008;87:S217–22. PubMed
Rewers A. Acute metabolic complications in diabetes. 2021.
Wachtel TJ. The diabetic hyperosmolar state. Clin Geriatr Med. 1990;6:797–806. PubMed
Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Diabetes Spectr. 2002;15:28–36.
Koul PB. Diabetic ketoacidosis: a current appraisal of pathophysiology and management. Clin Pediatr (Phila). 2009;48:135–44. PubMed
Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes. 2006;24:115–21.
Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention. World J Diabetes. 2021;12:2036. PubMed PMC
Sequeira RP. Central nervous system stimulants and drugs that suppress appetite. Side Eff Drugs Annu. 2009;31:1–15.
Schep LJ, Slaughter RJ, Beasley DMG. The clinical toxicology of metamfetamine. Clin Toxicol. 2010;48:675–94. PubMed
Schwarzbach V, Lenk K, Laufs U. Methamphetamine-related cardiovascular diseases. ESC Heart Fail. 2020;7:407–14. PubMed PMC
Herbeck DM, Brecht M-L, Lovinger K. Mortality, causes of death, and health status among methamphetamine users. J Addict Dis. 2015;34:88–100. PubMed PMC
Boyer EW, Seifert SA, Hernon C, Burns M. Methamphetamine: acute intoxication. UpToDate Accessed. 2019;6:22.